Edap Tms S.A. (NASDAQ:EDAP – Get Rating) was the recipient of a significant decrease in short interest in March. As of March 31st, there was short interest totalling 25,400 shares, a decrease of 25.1% from the March 15th total of 33,900 shares. Currently, 0.1% of the shares of the company are short sold. Based on an average daily volume of 80,500 shares, the days-to-cover ratio is currently 0.3 days.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in EDAP. Royal Bank of Canada acquired a new position in shares of Edap Tms during the second quarter valued at approximately $35,000. Envestnet Asset Management Inc. purchased a new stake in shares of Edap Tms in the fourth quarter valued at approximately $94,000. Toroso Investments LLC purchased a new position in Edap Tms in the third quarter worth approximately $126,000. Bank of America Corp DE raised its stake in shares of Edap Tms by 403.4% in the second quarter. Bank of America Corp DE now owns 42,959 shares of the medical equipment provider’s stock valued at $304,000 after acquiring an additional 34,426 shares in the last quarter. Finally, Fosun International Ltd raised its stake in Edap Tms by 1.7% in the fourth quarter. Fosun International Ltd now owns 179,039 shares of the medical equipment provider’s stock valued at $949,000 after buying an additional 3,000 shares in the last quarter. 27.20% of the stock is owned by institutional investors.
Several research analysts have recently commented on the company. Zacks Investment Research raised Edap Tms from a “sell” rating to a “hold” rating in a research note on Wednesday, April 6th. StockNews.com assumed coverage on Edap Tms in a research note on Thursday, March 31st. They issued a “hold” rating on the stock. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Buy” and an average target price of $11.33.
Edap Tms (NASDAQ:EDAP – Get Rating) last announced its earnings results on Wednesday, March 30th. The medical equipment provider reported $0.04 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.01 by $0.03. Edap Tms had a return on equity of 1.53% and a net margin of 1.51%. During the same quarter in the prior year, the business posted $0.03 EPS. As a group, equities research analysts predict that Edap Tms will post -0.08 earnings per share for the current year.
About Edap Tms (Get Rating)
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three divisions: High Intensity Focused Ultrasound (HIFU); Extracorporeal ShockWave Lithotripsy (ESWL); and Distribution.
- Get a free copy of the StockNews.com research report on Edap Tms (EDAP)
- Institutional Buying Puts A Bottom In Manpower Group Inc
- Workhorse Johnson & Johnson Plows New All-Time Highs
- Fastenal Stock is Ready to Sprint Higher
- J.B. Hunt Transportation Services Fires On All Cylinders
- 3 No-Brainer Stocks to Buy with $1000
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.